Results from an early safety study of Moderna Inc's coronavirus vaccine candidate in older adults showed that it produced virusneutralizing antibodies at levels similar to those seen in younger adults, with side effects roughly on par with highdose flu shots, researchers said on Tuesday.from Top Business News- News18.com
via IFTTT
No comments:
Post a Comment